Direct medical cost of type 2 diabetes in Singapore

Charmaine Shuyu Ng, Matthias Paul Han Sim Toh, Yu Ko, Joyce Yu Chia Lee

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Due to the chronic nature of diabetes along with their complications, they have been recognised as a major health issue, which results in significant economic burden. This study aims to estimate the direct medical cost associated with type 2 diabetes mellitus (T2DM) in Singapore in 2010 and to examine both the relationship between demographic and clinical state variables with the total estimated expenditure. The National Healthcare Group (NHG) Chronic Disease Management System (CDMS) database was used to identify patients with T2DM in the year 2010. DM-attributable costs estimated included hospitalisations, accident and emergency (A&E) room visits, outpatient physician visits, medications, laboratory tests and allied health services. All charges and unit costs were provided by the NHG. A total of 500 patients with DM were identified for the analyses. The mean annual direct medical cost was found to be $2,034, of which 61% was accounted for by inpatient services, 35% by outpatient services, and 4% by A&E services. Independent determinants of total costs were DM treatments such as the use of insulin only (p

Original languageEnglish
Article numbere0122795
JournalPLoS One
Volume10
Issue number3
DOIs
Publication statusPublished - Mar 27 2015

Fingerprint

Singapore
Medical problems
noninsulin-dependent diabetes mellitus
Type 2 Diabetes Mellitus
Costs and Cost Analysis
health services
Costs
Health
Delivery of Health Care
Ambulatory Care
accidents
Disease Management
Health Expenditures
chronic diseases
physicians
drug therapy
Health Services
management systems
Accidents
diabetes

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Ng, C. S., Toh, M. P. H. S., Ko, Y., & Lee, J. Y. C. (2015). Direct medical cost of type 2 diabetes in Singapore. PLoS One, 10(3), [e0122795]. https://doi.org/10.1371/journal.pone.0122795

Direct medical cost of type 2 diabetes in Singapore. / Ng, Charmaine Shuyu; Toh, Matthias Paul Han Sim; Ko, Yu; Lee, Joyce Yu Chia.

In: PLoS One, Vol. 10, No. 3, e0122795, 27.03.2015.

Research output: Contribution to journalArticle

Ng, Charmaine Shuyu ; Toh, Matthias Paul Han Sim ; Ko, Yu ; Lee, Joyce Yu Chia. / Direct medical cost of type 2 diabetes in Singapore. In: PLoS One. 2015 ; Vol. 10, No. 3.
@article{070cc083c96446b483bd11cc181c0b37,
title = "Direct medical cost of type 2 diabetes in Singapore",
abstract = "Due to the chronic nature of diabetes along with their complications, they have been recognised as a major health issue, which results in significant economic burden. This study aims to estimate the direct medical cost associated with type 2 diabetes mellitus (T2DM) in Singapore in 2010 and to examine both the relationship between demographic and clinical state variables with the total estimated expenditure. The National Healthcare Group (NHG) Chronic Disease Management System (CDMS) database was used to identify patients with T2DM in the year 2010. DM-attributable costs estimated included hospitalisations, accident and emergency (A&E) room visits, outpatient physician visits, medications, laboratory tests and allied health services. All charges and unit costs were provided by the NHG. A total of 500 patients with DM were identified for the analyses. The mean annual direct medical cost was found to be $2,034, of which 61{\%} was accounted for by inpatient services, 35{\%} by outpatient services, and 4{\%} by A&E services. Independent determinants of total costs were DM treatments such as the use of insulin only (p",
author = "Ng, {Charmaine Shuyu} and Toh, {Matthias Paul Han Sim} and Yu Ko and Lee, {Joyce Yu Chia}",
year = "2015",
month = "3",
day = "27",
doi = "10.1371/journal.pone.0122795",
language = "English",
volume = "10",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "3",

}

TY - JOUR

T1 - Direct medical cost of type 2 diabetes in Singapore

AU - Ng, Charmaine Shuyu

AU - Toh, Matthias Paul Han Sim

AU - Ko, Yu

AU - Lee, Joyce Yu Chia

PY - 2015/3/27

Y1 - 2015/3/27

N2 - Due to the chronic nature of diabetes along with their complications, they have been recognised as a major health issue, which results in significant economic burden. This study aims to estimate the direct medical cost associated with type 2 diabetes mellitus (T2DM) in Singapore in 2010 and to examine both the relationship between demographic and clinical state variables with the total estimated expenditure. The National Healthcare Group (NHG) Chronic Disease Management System (CDMS) database was used to identify patients with T2DM in the year 2010. DM-attributable costs estimated included hospitalisations, accident and emergency (A&E) room visits, outpatient physician visits, medications, laboratory tests and allied health services. All charges and unit costs were provided by the NHG. A total of 500 patients with DM were identified for the analyses. The mean annual direct medical cost was found to be $2,034, of which 61% was accounted for by inpatient services, 35% by outpatient services, and 4% by A&E services. Independent determinants of total costs were DM treatments such as the use of insulin only (p

AB - Due to the chronic nature of diabetes along with their complications, they have been recognised as a major health issue, which results in significant economic burden. This study aims to estimate the direct medical cost associated with type 2 diabetes mellitus (T2DM) in Singapore in 2010 and to examine both the relationship between demographic and clinical state variables with the total estimated expenditure. The National Healthcare Group (NHG) Chronic Disease Management System (CDMS) database was used to identify patients with T2DM in the year 2010. DM-attributable costs estimated included hospitalisations, accident and emergency (A&E) room visits, outpatient physician visits, medications, laboratory tests and allied health services. All charges and unit costs were provided by the NHG. A total of 500 patients with DM were identified for the analyses. The mean annual direct medical cost was found to be $2,034, of which 61% was accounted for by inpatient services, 35% by outpatient services, and 4% by A&E services. Independent determinants of total costs were DM treatments such as the use of insulin only (p

UR - http://www.scopus.com/inward/record.url?scp=84946164080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946164080&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0122795

DO - 10.1371/journal.pone.0122795

M3 - Article

VL - 10

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 3

M1 - e0122795

ER -